Marcgrave and Piso's plants for sale: The presence of plant species and names from the Historia Naturalis Brasiliae (1648) in contemporary Brazilian markets.

ETHNOPHARMACOLOGICAL RELEVANCE: Parallelisms between current and historical medicinal practices as described in the seventeenth century treatise Historia Naturalis Brasiliae (HNB) provide us with an overview of traditional plant knowledge transformations. Local markets reflect the actual plant use in urban and rural surroundings, allowing us to trace cross-century similarities of ethnobotanical knowledge. AIMS OF THE STUDY: We aim to verify in how far the HNB, created in seventeenth-century northeastern Brazil, correlates with contemporary plant use in the country by comparing the plant knowledge therein with recent plant market surveys at national level. MATERIALS AND METHODS: We conducted a literature review on ethnobotanical market surveys in Brazil. We used the retrieved data on plant composition and vernacular names, together with our own fieldwork from the Ver-o-Peso market in Belém, to compare each market repertoire with the useful species in the HNB. We analyzed similarities among markets and the HNB with a Detrended Correspondence Analysis and by creating Venn diagrams. We analyzed the methods of the different markets to check whether they influenced our results. RESULTS: Out of the 24 markets reviewed, the greatest similarities with the HNB are seen in northern Brazilian markets, both in plant composition and vernacular names, followed by the northeast. The least overlap is found with markets in the central west and Rio de Janeiro. Most of the shared vernacular names with the HNB belonged to languages of the Tupi linguistic family. CONCLUSION: The similarity patterns in floristic composition among Brazilian markets and the HNB indicate the current wider distribution and trade of the species that Marcgrave and Piso described in 1648 in the northeast. Migration of indigenous groups, environmental changes, globalized and homogenous plant trade, and different market survey methods played a role in these results. The HNB is a reference point in time that captures a moment of colonial cultural transformations.

Is there nothing new under the sun? The influence of herbals and pharmacopoeias on ethnobotanical traditions in Albacete (Spain).

ETHNOPHARMACOLOGICAL RELEVANCE: This paper has two overarching aims: (1) presenting the results of studying the Albacete tariff of medicines of 1526 and (2) broadly analyzing the origin and influences of medicinal traditional knowledge in the region of Albacete, Spain. We use historical and modern literature that may have influenced this knowledge. Our primary goal was to determine the ingredients used in the pharmacy in the 16th century CE in Albacete through the analysis of the tariff, and our secondary goal was to investigate until when ingredients and uses present in pharmacy and herbals persisted in later periods. METHODS: The identity of medicines and ingredients was determined by analyzing contemporary pharmacopoeias and classical pharmaceutical references. We analyzed further 21 sources (manuscripts, herbals, and books of medicines, pharmacopoeias, pharmacy inventories, and modern ethnobotanical records) for the presence/absence of ingredients and complex formulations of the tariff. Using factorial and cluster analysis and Bayesian inference applied to evolution models (reversible-jump Markov chain Monte Carlo), we compared textual sources. Finally, we analyzed the medicinal uses of the top 10 species in terms of frequency of citation to assess the dependence of modern ethnobotanical records on Renaissance pharmacy and herbals, and, ultimately, on Dioscorides. RESULTS: In Albacete 1526, we determined 101 medicines (29 simple drugs and 72 compound medicines) comprising 187 ingredients (85% botanical, 7.5% mineral, and 7.5% zoological substances). All composed medicines appear standardized in the pharmacopoeias, notably in the pharmacopoeia of Florence from 1498. However, most were no longer in use by 1750 in the pharmacy, and were completely absent in popular herbal medicine in Albacete 1995 as well as in Alta Valle del Reno (Italy) in 2014. Among the ingredients present in different formulation are the flowers of Rosa gallica, honey (Apis mellifera), the roots of Nardostachys jatamansi, and Convolvulus scammonia, pistils of Crocus sativus, grapes and raisins (Vitis vinifera), rhizomes of Zingiber officinale, bark of Cinnamomum verum, leaves and fruits of Olea europaea, mastic generally of Pistacia lentiscus, and wood of Santalum album. The statistical analysis of sources produces four well-separated clusters (Renaissance Herbals and Pharmacopoeias, Ethnobotany and Folk Medicine, Old phytotherapy, and Modern phytotherapy including Naturopathy) confirming our a priori classification. The clade of Renaissance Herbals and Pharmacopoeias appears separated from the rest in 97% of bootstrapped trees. Bayesian inference produces a tree determined by an initial set of two well-distinct core groups of ingredients: 64, locally used in Mediterranean Europe during centuries; and 45, imported, used in pharmacy during centuries. Complexity reached its maximum in Albacete 1526 and contemporary pharmacopoeias, gradually decreasing over time. The analysis of medicinal uses of the top 10 ingredients showed low coincidence between Dioscorides and different Renaissance herbals or medical treatises and of all of them with ethnobotany in Albacete. CONCLUSIONS: Regarding our question: is there something new under the sun? In some aspects, the answer is "No". The contrast between expensive drugs, highly valued medicines, and unappreciated local wild medicinal plants persists since the Salerno's school of medicine. Old medicine in Mediterranean Europe, as reflected by Albacete 1526 tariff of medicines, involved strict formulations and preferences for certain ingredients despite other ingredients locally available but underappreciated. This confirms the fact that any system of medicine does not get to use all available resources. Ethnobiological records of materia medica, in rural areas of Albacete, describe systems with a high degree of stability and resilience, where the use of local resources, largely wild but also cultivated, is predominant in contrast with the weight of imported exotic products in pharmacy.

[The company Willmar Schwabe in the Nazi era]. / Die Firma Willmar Schwabe in der NS-Zeit.

This essay follows the history of the Schwabe Company between 1933 and 1945 when it, like all other companies at the time, had to subject to the state-enforced conformity ('Gleichschaltung'). While Willmar Schwabe II (1878-1935), the company's second director, kept clear of Nazi politics, both of his sons, who succeeded him at an early age, became members of the Nazi party: Willmar III (1907-1983) probably from initial conviction and Wolfgang (1912-2000), who joined in 1937, more likely for opportunistic reasons. The two lay journals published by Schwabe--the Leipziger Populäre Zeitschrift für Homöopathie and the Biochemische Monatsblätter--embraced the Nazi ideology more thoroughly than the general homeopathic journal Allgemeine Homöopathische Zeitung, including above all contributions on racial hygiene. Our research has revealed that Schwabe only employed foreign workers from 1942 on, that their number was much lower, at 0.9 per cent in 1942 and 3.6 per cent in 1944, than that of other pharmaceutical companies and that their pay hardly differed from that of German workers. The sales and profit figures investigated have shown that the company did not profit exceptionally from the new Nazi health policies ('Neue Deutsche Heilkunde'): while its sales and profits rose in the Nazi era due to the increased use of medication among the civil population during wartime, the drugs produced by Schwabe remained marginal also during the war, as is apparent also from its modest deliveries to the army. All in all one can conclude that the company offered neither resistance nor particular support to the Nazi ideology.

World trade in medicinal plants from Spanish America, 1717-1815.

This article outlines the history of the commerce in medicinal plants and plant-based remedies from the Spanish American territories in the eighteenth century. It maps the routes used to transport the plants from Spanish America to Europe and, along the arteries of European commerce, colonialism and proselytism, into societies across the Americas, Asia and Africa. Inquiring into the causes of the global 'spread' of American remedies, it argues that medicinal plants like ipecacuanha, guaiacum, sarsaparilla, jalap root and cinchona moved with relative ease into Parisian medicine chests, Moroccan court pharmacies and Manila dispensaries alike, because of their 'exotic' charisma, the force of centuries-old medical habits, and the increasingly measurable effectiveness of many of these plants by the late eighteenth century. Ultimately and primarily, however, it was because the disease environments of these widely separated places, their medical systems and materia medica had long become entangled by the eighteenth century.

Brazilian medicinal plants described by 19th century European naturalists and in the Official Pharmacopoeia.

ETHNOPHARMACOLOGICAL RELEVANCE: The American flora represents one of the world's wealthiest sources of material with pharmacological activity due to its biodiversity. Medicinal plants are widely used as home remedies in Brazil but several species used are native of other continents and were introduced here since the colonization, beginning in 1500. The Traditional Medicine Division of the WHO recognizes the importance of plant species used by the Amerindian as medicines, and recommends that their efficacies should be evaluated through pharmacological and toxicological assays. AIM OF THE STUDY: To verify which Brazilian medicinal plants, especially those of Amerindian origin, were used in 19th century and have been evaluated by pharmacological studies. MATERIALS AND METHODS: Data about the use of native plants in traditional medicine were searched in bibliographic material from European naturalists who traveled throughout Minas Gerais in the 19th century. RESULTS AND CONCLUSION: Two hundred and three species were described as useful by these naturalists and thirty-nine of them were also included in the first edition of Brazilian Official Pharmacopoeia (FBRAS) in 1929, showing their use also in conventional medicine. Seventeen species have medicinal properties of Amerindian origin but despite the long tradition of medicinal plant use, only nine have been evaluated by pharmacological studies. That the studies which have been conducted to date have in each case confirmed the traditional uses of the plants examined. We suggest that the remaining species must be regarded as a priority for pharmacological studies, as they have promising phytotherapeutic potential.

[From the plant to chemistry--the early history of "rheumatic medication"]. / Von der Pflanze zur Chemie--die Frühgeschichte der "Rheumamittel".

The empirical administration of medication of plant, animal and even mineral origin goes back thousands of years. It was only in the 19th century that such therapy gained a scientific basis by means of the possibility to extract the active substances and analyze them chemically, and ultimately create them synthetically and modify them chemically.Meadow saffron was used from the 2nd century BC for the treatment of joint disease and gout; the active ingredient colchicine was discovered in 1819. For 4000 years willow bark has also been considered a remedy against fever, pain and gout. The active ingredient salicin was isolated in 1829, followed by salicyl acid in 1838, while the better tolerated acetylsalicylic acid was synthesized in 1897. Although the antipyretic agent cinchona was never a rheumatic remedy, it was initially considered an important antiinflammatory medication. In 1844, during the search for an alternative to quinin, antipyrin was developed, from which many antiphlogistic, antipyretic and analgetic active substances were later derived. Following the Second World War, the strongest antiinflammatory drug, cortisone, was discovered, derivates of which are still indispensable today for the treatment of inflammatory rheumatic diseases. At about the same time, there was a new wave of research which lead to the development of a large number of so-called non-steroidal antiinflammatory drugs. Following the discovery of proinflammatory cytokines in the 1970s, it became possible in the 1990s to produce antibodies against these substances, which gave rheumatic therapy new perspectives in the form of "biologicals". The sap from poppy seed capsules was already considered to have analgesic properties in the time of Hippocrates. The active ingredient morphine was isolated at the beginning of the 19th century. Today, only synthetically produced"opioids" are used, if at all, for the treatment of rheumatic disease.

Novas práticas sociais na constituição do direito à saúde: a experiência de um movimento fitoterápico comunitário / New social practices constituting the right to health: the experience of a community phytotherapy movement

O objetivo deste trabalho foi analisar como a experiência de um movimento popular se afirma como um campo de constituição do direito à saúde. Para tanto, partimos da problematização da concepção de direito à saúde usualmente referida na reforma sanitária brasileira, procurando afirmar as dimensões constituintes dos movimentos societários. Nosso objeto de estudo foi a experiência das farmácias fitoterápicas da Pastoral da Saúde, nos municípios de Vitória e Vila Velha, ES, Brasil. Como resultado, identificamos três aspectos da experiência comunitária desse movimento que concorrem para a afirmação de outras práticas e sentidos de saúde: o recurso à fitoterapia, as relações de cuidado e a rede de vínculos sociais baseados na solidariedade. Por meio deles observamos que o fazer da Pastoral da Saúde estabelece uma contraposição com os dispositivos e mecanismos de poder que configuram o campo da saúde, abrindo novas possibilidades de constituição de direitos de cidadania.

The aim of this study was to analyze how experiences within a popular movement have been affirmed as a field for constituting healthcare rights. The starting point was the question posed by the usual concept of healthcare rights cited in relation to Brazilian healthcare reforms, in seeking to affirm the constituent dimensions of movements within society. The study focused on experiences of phytotherapeutic pharmacies belonging to healthcare chaplaincies in the municipalities of Vitória and Vila Velha, ES, Brazil. The result was that we identified three aspects of the community experience of this movement that contribute towards affirming other practices and meanings within healthcare: phytotherapy usage, care-based relationships and solidarity-based social networks. Through these, we observed that healthcare chaplaincies' actions establish a counterbalance to the power devices and mechanisms that constitute the field of healthcare, thus opening up new possibilities for constructing citizenship rights.

El objeto de este trabajo ha sido analizar como la experiencia de un movimiento popular se afirma como un campo de constitución del derecho a la salud. Para tanto, partimos de la problematización de la concepción de derecho a la salud usualmente referida en la reforma sanitaria brasileña, buscando afirmar las dimensiones constituyentes de los movimientos societarios. Nuestro objeto de estudio fue la experiencia de las farmacias fitoterapéuticas de la Pastoral de la Salud, en las ciudades de Vitória e Vila Velha, estado de Espírito Santo, Brasil. Como resultado, identificamos tres aspectos de la experiencia comunitaria de ese movimiento que contribuyen para la afirmación de otras prácticas y sentidos de salud. Son ellos: el recurso a la fitoterapia, las relaciones de cuidado y la red de vínculos sociales basados en la solidariedad. Por medio de ellos observamos que el hacer de la Pastoral de la Salud establece una contraposición con los dispositivos y mecanismos de poder que configuran el campo de la salud, abriendo nuevas posibilidades de constitución de derechos de ciudadanía.

[Surgical practice in the Mexican Empire]. / El ejercicio de la cirugía en el imperio mexica.

The prehispanic medicines of Mexico are considered as testimony of the splendor of the Meso-American cultures; their great scientific advance and technical allowed them to accumulate a vast collection of clinical and pathological data based on the observation and experimentation. They integrated a nomenclature medical surgical that reflected their advance in those fields of the knowledge, where the anatomy and surgery occupied a preponderant paper. The medicine was known generically as ticiotl, of where it derives the term tícitl for the doctor. In their concept health-illness the limits among the magic, religion and the empiricism for natural causes were not clear, therefore they considered that the divine, human or natural origin of the illnesses influenced in an important way in its nature. Inside this complex causal system, the illnesses caused by the gods, spirits and celestial beings were considered as hot, while those caused by beings of the other realm were cold. The practice of the medicine had a very established organization designing a very advanced system of specialties that allowed them to accumulate a vast experience for the handling of chronic and acute illnesses in different progression phases, which managed with an integral therapy that had a plurality of resources of vegetable origin, animal, and mineral. The surgery was designated as texoxotlaliztli and its cures tepatiliztli. The surgeon was designated as texoxotlaticitl and it developed advanced techniques in the handling of sutures, wounded, drainage of abscesses, fractures and joint dislocations, pterygium, tonsillitis, circumcision, and amputations.

Antidiabetic drugs used in Europe prior to the discovery of insulin.

Many therapeutic agents had been used for the treatment of diabetes mellitus before insulin was discovered and several hundred plants have shown some extent of antidiabetic activity. This study tries to explore which agents were most widely used in Europe in the pre-insulin era. According to the scientific literature and the proprietary drug industry around 1900, more than 100 agents were considered to have hypoglycemic activity. Most of them seem to have been used only occasionally while some others were recommended and marketed to a large extent. Among the medicinal plants, Syzygium cumini (syn. S. jambolanum, Eugenia jambolana), Vaccinum myrtillus and Phaseolus sp. were most common, and other frequently used agents were opium, opium alkaloids, other alkaloids like quinine or Belladonna alkaloids, salicylates, alkaline substances like sodium (bi)carbonate and even strong poisons like arsenic or uranium salts. Syzygium jambolanum seed powder seems to be one of the most intensively studied antidiabetic agents of plant origin.

The story so far in R&D.

Human diseases are a significant cause of suffering and mortality and lead to a consequential need for effective therapies. The need for therapy is as old as human history itself. Therapy has progressed from an age of administration of herbal remedies and organ extracts to an era of serendipitous drug discovery, when the pharmaceutical industry was born, to the dominance of medicinal chemistry and more recently, to the revolutionary advances--genetic engineering and monoclonal antibody technology, high-speed technologies, gene therapy and the deciphering of the human genome--which promise the discovery of completely new targets for new medicines as well as the great potential of personalized therapy.

[Pharmaceutical industry and "New German Medicine" ("Neue Deutsche Heilkunde")]. / Pharmazeutische Industrie und "Neue Deutsche Heilkunde".

THe so-called "New German Medicine", initially propagated in the health policy of the National Socialist Party, promoted greater use of phytotherapeutic and homeopathic drugs by the medical community. In response, the "Reichsfachschaft der pharmazeutischen Industrie e. V." (Association of Pharmaceutical Industry of the Reich") was obliged to pursue a carefully chosen double strategy, given that the members of the Association were both manufacturers of natural remedies and manufacturers of allopathic drugs.However, the fact that I.G. Farben completely ignored the "New German Medicine" suggests that the large chemical-pharmaceutical manufacturers did not take this policy very seriously. The only documents pertaining to increased research in the area of natural remedies stem from the medium-sized manufacturers Knoll and Schering. In the case of both companies it is noteworthy that they worked towards obtaining a scientific foundation for the developed preparates, and that they employed conventional methods of chemical analysis and proof of activity. THe growth of the classical manufacturers of natural remedies, such as the company Willmar Schwabe was, as far as any growth at all could be observed, significantly smaller than had been theoretically postulated. There is no casual relationship between any commercial success during the period in which the Nazis were in power and today's commercial prosperity.Moreover, from the viewpoint of the pharmaceutical industry, the "New German Medicine" seems to have passed its zenith before 1936, when the 4-year plan for war preparation entered into force.

Native American drug therapy: United States and Canada.

The more than one hundred different Native American Indian cultures of the United States and Canada developed a rich pharmacopoeia before contact with Europeans began in the fifteenth century. Together these Native American groups contributed 220 indigenous drugs to "The Pharmacopoeia of the United States of America". Some of these remedies are used today in North America, Europe and elsewhere.